Uncertainty reigns, but opportunity persists for biotech’s 2025
Pathfinders in Biopharma ›09:17 | Feb 7th
Universal wisdom had it that a Republican sweep in the U.S. election would favor biotech. Appointments to the new administration’s healthcare leadership make that far less certain. What effect will th...Show More
Recommendations